Thermal cycling stage in the optimization of the freezing processes in the technology of drug lyophilized

Introduction . In the lyophilization technology, the freezing stage plays a key role in determining the time of primary sublimation, secondary desorption, and often the appearance of the lyophilisate. The duration of lyophilization is related to the composition and freezing conditions through the parameter resistance to mass transfer, which depends on the size of ice crystals.
Objective: to select temperature regimes of thermal cycling (“annealing”) to obtain the most vapor-permeable sublimation layer, calculate the value of resistance to mass transfer of water and select the most optimal lyophilization mode for preparing lyophilisate GK-2 for preparing solutions for injections.
Materials and methods . Substance: GK-2 (hexamethyleneamide bis-(N-monosuccinyl-L-glutamyl-L-lysine)) (V.V. Zakusov Research Institute of Pharmacology, Russia); excipients intended for parenteral use: lyoprotector – sucrose (CompriSugar®) (CristalUnion, France), cryoprotector – polyethylene glycol 4000 (PEG, macrogol) (Polyglykol® 4000, Panreac, Spain). Edwards EF-6 Lyophilic Dryer (Italy); microscope Nikon Eclipse E200; digital camera Nikon DS-Ri2; confocal microscope LEXT OLS 4100. Various freezing, lyophilization, direct optical microscopy in a cold chamber, laser microscopy and mathematical formulas were used to determine the values of resistance to mass transfer of water vapor from model lyophilisates.
Results . This article discusses the possibilities of optimizing the freezing stage and, accordingly, the entire lyophilization cycle by introducing an intermediate thermal cycling stage, provides calculations of the mass transfer coefficient of the composition under different freezing conditions and ice crystal sizes.
Conclusion . A simplified equation for calculating the coefficient of resistance to mass transfer for model solutions of GK-2 based on the correlation dependence was determined. The selection of freezing and “annealing” modes was carried out on the basis of the most important indicators, such as productivity and time of lyophilization.

1. Гулякин И.Д., Хашем А., Николаева Л.Л. и др. Разработка новой технологии получения лекарственной формы для внутривенного введения производного индолокарбазола ЛХС-1208. Российский биотерапевтический журнал 2016;15(2):55–60. [Gulyakin I.D., Hashem A., Nikolaeva L.L. et al. Development of a new technology for the preparation of a dosage form for the intravenous administration of an indole carbazole derivative LHS-1208. Rossiysky bioterapevtichesky zhurnal = Russian Journal of Biotherapy 2016;15(2):55–60. (In Russ.)]. DOI: 10.17650/1726-9784-2016-15-2-55-60.

2. Аршинова О.Ю., Оборотова Н.А., Санарова Е.В. Вспомогательные вещества в технологии лиофилизации лекарственных препаратов. Разработка и регистрация лекарственных средств 2013;(2):20–5. [Arshinova O.Yu., Oborotova N.A., Sanarova E.V. Auxiliary substances in the technology of lyophilization of drugs. Razrabotka i registratsiya lekarstvennykh sredstv = Development and Registration of Medicines 2013;(2):20–5. (In Russ.)].

3. Блынская Е.В., Тишков С.В., Алексеев К.В., Марахова А.И. Вспомогательные вещества в технологии лиофилизации пептидов и белков. Фармация 2017;66(1):14–8. [Blynskaya E.V., Tishkov S.V., Alekseev K.V., Marakhova A.I. Auxiliary substances in the technology of lyophilization of peptides and proteins. Farmatsiya = Pharmacy 2017;66(1):14–8. (In Russ.)].

4. Блынская Е.В., Тишков С.В., Алексеев К.В. Технологические подходы к совершенствованию процесса лиофилизации белковых и пептидных лекарственных препаратов. Российский биотерапевтический журнал 2017;16(1):6–11. [Blynskaya E.V., Tishkov S.V., Alekseev K.V. Technological approaches to improving the process of lyophilization of protein and peptide drugs. Rossiysky bioterapevtichesky zhurnal = Russian Journal of Biotherapy 2017;16(1):6–11. (In Russ.)]. DOI: 10.17650/1726-9784-2017-16-1-6-11.

5. Блынская Е.В., Тишков С.В., Алексеев К.В., Минаев С.В. Математическое моделирование этапа замораживания в технологии лиофилизированных лекарственных форм. Российский биотерапевтический журнал 2018;17(2):15–21. [Blynskaya E.V., Tishkov S.V., Alekseev K.V., Minaev S.V. Mathematical modeling of the freezing stage in the technology of lyophilized drug forms. Rossiysky bioterapevtichesky zhurnal = Russian Journal of Biotherapy 2018;17(2):15–21. (In Russ.)]. DOI: 10.17650/1726-97842018-17-2-15-21.

6. Поварнина П.Ю., Воронцова О.Н., Гудашева Т.А. и др. Оригинальный дипептидный миметик фактора роста нервов ГК-2 восстанавливает нарушенные когнитивные функции в крысиных моделях болезни Альцгеймера. Acta Naturae (русскоязычная версия) 2013;5(3):48–52. [Povarnina P.Yu., Vorontsova O.N., Gudasheva T.A. et al. The original dipeptide mimetik of the nerve growth factor GK-2 restores impaired cognitive functions in rat models of Alzheimer’s disease. Acta Naturae (Russian version) 2013;5(3):48–52. (In Russ.)].

7. Hottot A., Vessot S., Andrieu J. Freeze drying of pharmaceuticals in vials: Influence of freezing protocol and sample configuration on ice morphology and freeze-dried cake texture. Chemical Engineering and Processing: Process Intensification 2007;46(7):666–74. DOI: 10.1016/j.cep.2006.09.003.

8. Serp D., Mueller M., von Stockar U., Marison I.W. Low-temperature electron microscopy for the study of polysaccharide ultrastructures in hydrogels. II. Effect of temperature on the structure of Ca2+-alginate beads. Biotechnol Bioeng 2002;79(3):253–9. DOI: 10.1002/bit.10287. PMID: 12115413.

9. Caillet A., Cogné C., Andrieu J. et al. Characterization of ice cream structure by direct optical microscopy. Influence of freezing parameters. LWT-Food Science and Technology 2003;36(8):743–9. DOI: 10.1016/S0023-6438(03)00094-X.